VENTAS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.64 USD | +0.97% |
|
-1.23% | -14.45% |
| Mar. 18 | Evercore ISI Upgrades Ventas to Outperform From In Line, Price Target is $50 | MT |
| Mar. 12 | Ventas, Inc. Declares First Quarter 2024 Dividend, Payable on April 18, 2024 | CI |
Financials (USD)
| Sales 2024 * | 4.8B | Sales 2025 * | 5.07B | Capitalization | 17.01B |
|---|---|---|---|---|---|
| Net income 2024 * | -534M | Net income 2025 * | -262M | EV / Sales 2024 * | 6.3 x |
| Net Debt 2024 * | 13.21B | Net Debt 2025 * | 13.23B | EV / Sales 2025 * | 5.96 x |
| P/E ratio 2024 * |
-32.7
x | P/E ratio 2025 * |
-53.9
x | Employees | 486 |
| Yield 2024 * |
4.37% | Yield 2025 * |
4.56% | Free-Float | 99.35% |
More Fundamentals
* Assessed data
More news
Latest transcript on Ventas, Inc.
More recommendations
More press releases
More news
| 1 day | +0.97% | ||
| 1 week | -1.23% | ||
| Current month | -2.07% | ||
| 1 month | -0.30% | ||
| 3 months | -10.42% | ||
| 6 months | -1.23% | ||
| Current year | -14.45% |
1 week
41.45
43.21
1 month
41.4544.10
Current year
41.4550.61
1 year
39.3350.99
3 years
35.3364.02
5 years
13.3575.40
10 years
13.3581.93
| Managers | Title | Age | Since |
|---|---|---|---|
Debra Cafaro
CEO | Chief Executive Officer | 66 | 98-12-31 |
Bob Probst
DFI | Director of Finance/CFO | 56 | 14-10-26 |
| Chief Tech/Sci/R&D Officer | - | 19-01-24 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michael Embler
BRD | Director/Board Member | 59 | 22-03-06 |
Matthew Lustig
BRD | Director/Board Member | 63 | 11-05-11 |
Marguerite Nader
BRD | Director/Board Member | 55 | 20-07-05 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.03% | 208 M€ | -.--% | ||
| 1.91% | 285 M€ | -5.34% | ||
| 1.43% | 130 M€ | -1.54% | ||
| 0.99% | 0 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 42.64 | +0.97% | 1,857,120 |
| 24-04-17 | 42.23 | +1.32% | 1,645,602 |
| 24-04-16 | 41.68 | -1.33% | 1,577,788 |
| 24-04-15 | 42.24 | -1.38% | 1,335,292 |
| 24-04-12 | 42.83 | -0.79% | 1,880,836 |
Delayed Quote Nyse, April 18, 2024 at 04:00 pm EDT
More quotes
Ventas, Inc. specializes in owning and managing healthcare and medical-residential facilities.
At the end of 2022, the group's portfolio included 1,237 assets consisting primarily of senior housing (802), medical office buildings (313), rehabilitation and long-term acute care facilities (36), laboratories and research facilities (32), skilled nursing facilities (16), medical and surgical facilities (13).
Net sales are distributed geographically as follows: the United States (88.5%), Canada (10.9%) and the United Kingdom (0.6%).
Sector
Specialized REITs
Calendar
2024-04-30
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
42.64
USD
Average target price
52.47
USD
Spread / Average Target
+23.06%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -14.45% | 17.01B | |
| +0.71% | 53.02B | |
| -9.04% | 12.82B | |
| -2.22% | 7.35B | |
| -19.97% | 5.24B | |
| +6.08% | 3.18B | |
| -9.27% | 2.9B | |
| +1.63% | 2.89B | |
| +8.22% | 2.59B | |
| -12.82% | 2.43B |
- Stock Market
- Equities
- VTR Stock
